GSDME and lung cancer: Zhang et al.17found that in lung cancer cells, cisplatin and paclitaxel can activate CASP3 to promote the production of N‐terminal fragments of GSDME and cause pyroptosis; caspases‐4 (CASP4) is involved in another pathway of pyroptosis.